Kessler, Torsten
Koschmieder, Steffen
Schliemann, Christoph
Crysandt, Martina
Mikesch, Jan-Henrik
von Stillfried, Saskia
Stelljes, Matthias
Pohlen, Michele
Lenz, Georg
Kirsch, Anna
Vehring, Kerstin
Wardelmann, Eva
Hartmann, Wolfgang
Bormann, Eike
Gerss, Joachim
Brümmendorf, Tim H.
Müller-Tidow, Carsten
Berdel, Wolfgang E. http://orcid.org/0000-0002-3030-6567
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (EXC 1003)
GlaxoSmithKline (None)
Novartis Pharma (None)
Article History
Received: 1 November 2018
Accepted: 2 March 2019
First Online: 21 March 2019
Compliance with ethical standards
: Institutional review board or independent ethics committee approval and written informed consent from all patients for being included in the study were obtained. The study was performed in accordance with the ethical principles of the Declaration of Helsinki and in compliance with national laws.
: Dr. Koschmieder declares Consultancy, Honoraria, and Research Funding by Novartis. Dr. Stelljes declares Pfizer Consultancy, Honoraria and Research Funding; MSD Consultancy; JAZZ Honoraria; Amgen Honoraria; Novartis Honoraria. Dr. Lenz reports the following: Celgene Corp. Consultancy, Honoraria, Travel, Accommodations, Expenses, Research Funding and Speakers Bureau; Janssen Consultancy, Honoraria, Travel, Accommodations, Expenses, Research Funding and Speakers Bureau; Roche Consultancy, Honoraria, Travel, Accomodations, Expenses, and Research Funding; Bayer Consultancy, Honoraria, Research Funding and Speakers Bureau; Novartis Research Funding; Gilead Consultancy and Honoraria. Dr. Brümmendorf reports Pfizer Consultancy and Research Funding, Novartis Consultancy and Research Funding, Takeda Consultancy, Janssen Consultancy, and Merck Consultancy. Dr. Müller-Tidow reports Pfizer Research Funding. Dr. Berdel reports research grants by GSK and Novartis. The other authors declare that they have no conflict of interest.